Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	acetyl-CoA carboxylase activity	ACACA ACACB	2.15e-05	2	93	2	GO:0003989
GeneOntologyMolecularFunction	translation initiation factor activity	EIF3C EIF3J COPS5 EIF3CL	9.32e-05	51	93	4	GO:0003743
GeneOntologyMolecularFunction	CoA carboxylase activity	ACACA ACACB	3.18e-04	6	93	2	GO:0016421
GeneOntologyMolecularFunction	biotin binding	ACACA ACACB	3.18e-04	6	93	2	GO:0009374
GeneOntologyMolecularFunction	ligase activity, forming carbon-carbon bonds	ACACA ACACB	4.44e-04	7	93	2	GO:0016885
GeneOntologyBiologicalProcess	malonyl-CoA biosynthetic process	ACACA ACACB	2.01e-05	2	93	2	GO:2001295
GeneOntologyBiologicalProcess	glycerolipid metabolic process	RGN BMX PI4KA CIDEC ABHD3 IP6K1 PLCG2 LCAT INPP5F SORL1	2.37e-05	429	93	10	GO:0046486
GeneOntologyBiologicalProcess	glycerolipid biosynthetic process	RGN BMX PI4KA ABHD3 IP6K1 PLCG2 LCAT INPP5F	2.87e-05	268	93	8	GO:0045017
GeneOntologyBiologicalProcess	formation of cytoplasmic translation initiation complex	EIF3C EIF3J EIF3CL	3.88e-05	15	93	3	GO:0001732
GeneOntologyBiologicalProcess	glycerophospholipid biosynthetic process	BMX PI4KA ABHD3 IP6K1 PLCG2 LCAT INPP5F	5.70e-05	217	93	7	GO:0046474
GeneOntologyBiologicalProcess	response to organic cyclic compound	TRPV1 IGF1R PTPRC GNA14 ACACA ACACB BRAF MAP1B NSG1 NAGLU GNA11 PLCG2 LCAT SSTR1 SDK1	6.63e-05	1048	93	15	GO:0014070
GeneOntologyBiologicalProcess	response to axon injury	IGF1R BRAF MAP1B PLCG2 INPP5F	1.13e-04	105	93	5	GO:0048678
GeneOntologyCellularComponent	eukaryotic translation initiation factor 3 complex	EIF3C EIF3J COPS5 EIF3CL	6.99e-07	16	95	4	GO:0005852
GeneOntologyCellularComponent	leading edge membrane	FAP TRPV1 BMX PSD PSD3 PLCG2 USH2A	4.89e-05	210	95	7	GO:0031256
GeneOntologyCellularComponent	eukaryotic 48S preinitiation complex	EIF3C EIF3J EIF3CL	7.06e-05	18	95	3	GO:0033290
GeneOntologyCellularComponent	eukaryotic 43S preinitiation complex	EIF3C EIF3J EIF3CL	8.36e-05	19	95	3	GO:0016282
GeneOntologyCellularComponent	translation preinitiation complex	EIF3C EIF3J EIF3CL	9.80e-05	20	95	3	GO:0070993
GeneOntologyCellularComponent	ruffle membrane	FAP BMX PSD PSD3 PLCG2	1.34e-04	108	95	5	GO:0032587
GeneOntologyCellularComponent	cell leading edge	FAP TRPV1 BMX PSD TRPV2 PSD3 PLCG2 USH2A PTK2	4.53e-04	500	95	9	GO:0031252
GeneOntologyCellularComponent	9+0 non-motile cilium	MAP1B TTLL4 PCDHB15 GNA11 USH2A	6.71e-04	153	95	5	GO:0097731
GeneOntologyCellularComponent	eukaryotic translation initiation factor 3 complex, eIF3m	EIF3C EIF3CL	7.21e-04	9	95	2	GO:0071541
Domain	Cupredoxin	HEPHL1 PRPF8 F5 PKHD1L1	3.61e-06	22	91	4	IPR008972
Domain	ACC_central	ACACA ACACB	2.35e-05	2	91	2	PF08326
Domain	EIF3C_N_dom	EIF3C EIF3CL	2.35e-05	2	91	2	IPR008905
Domain	eIF-3c_N	EIF3C EIF3CL	2.35e-05	2	91	2	PF05470
Domain	AcCoA_COase_cen	ACACA ACACB	2.35e-05	2	91	2	IPR013537
Domain	EIF3C	EIF3C EIF3CL	2.35e-05	2	91	2	IPR027516
Domain	TRAM1	TRAM1L1 TRAM1	7.02e-05	3	91	2	PF08390
Domain	Translocation_assoc_membrane	TRAM1L1 TRAM1	7.02e-05	3	91	2	IPR016447
Domain	TRAM1	TRAM1L1 TRAM1	7.02e-05	3	91	2	IPR013599
Domain	Carboxyl_trans	ACACA ACACB	1.40e-04	4	91	2	PF01039
Domain	COA_CT_CTER	ACACA ACACB	1.40e-04	4	91	2	PS50989
Domain	COA_CT_NTER	ACACA ACACB	1.40e-04	4	91	2	PS50980
Domain	Gprotein_alpha_Q	GNA14 GNA11	1.40e-04	4	91	2	IPR000654
Domain	TRPV1-4_channel	TRPV1 TRPV2	1.40e-04	4	91	2	IPR008347
Domain	COA_CT_N	ACACA ACACB	1.40e-04	4	91	2	IPR011762
Domain	COA_CT_C	ACACA ACACB	1.40e-04	4	91	2	IPR011763
Domain	Carboxyl_trans	ACACA ACACB	1.40e-04	4	91	2	IPR000022
Domain	fn3	FNDC1 IGF1R PTPRC USH2A SDK1 SORL1	1.41e-04	162	91	6	PF00041
Domain	Biotin_BS	ACACA ACACB	2.33e-04	5	91	2	IPR001882
Domain	Cu-oxidase_3	HEPHL1 F5	2.33e-04	5	91	2	IPR011707
Domain	Biotin_COase_C	ACACA ACACB	2.33e-04	5	91	2	IPR005482
Domain	BC	ACACA ACACB	2.33e-04	5	91	2	PS50979
Domain	MULTICOPPER_OXIDASE1	HEPHL1 F5	2.33e-04	5	91	2	PS00079
Domain	Cu_oxidase_CS	HEPHL1 F5	2.33e-04	5	91	2	IPR033138
Domain	Biotin_carb_C	ACACA ACACB	2.33e-04	5	91	2	SM00878
Domain	Biotin_carb_C	ACACA ACACB	2.33e-04	5	91	2	PF02785
Domain	Biotin_carboxylation_dom	ACACA ACACB	2.33e-04	5	91	2	IPR011764
Domain	CPSASE_1	ACACA ACACB	2.33e-04	5	91	2	PS00866
Domain	BIOTIN	ACACA ACACB	2.33e-04	5	91	2	PS00188
Domain	Cu-oxidase_3	HEPHL1 F5	2.33e-04	5	91	2	PF07732
Domain	FN3	FNDC1 IGF1R PTPRC USH2A SDK1 SORL1	2.89e-04	185	91	6	SM00060
Domain	Rudment_hybrid_motif	ACACA ACACB	3.48e-04	6	91	2	IPR011054
Domain	Cu_oxidase_Cu_BS	HEPHL1 F5	3.48e-04	6	91	2	IPR002355
Domain	CPSASE_2	ACACA ACACB	3.48e-04	6	91	2	PS00867
Domain	FN3	FNDC1 IGF1R PTPRC USH2A SDK1 SORL1	4.27e-04	199	91	6	PS50853
Domain	ATP_grasp_subdomain_2	ACACA ACACB TTLL4	4.56e-04	31	91	3	IPR013816
Domain	CbamoylP_synth_lsu-like_ATP-bd	ACACA ACACB	4.85e-04	7	91	2	IPR005479
Domain	BC-like_N	ACACA ACACB	4.85e-04	7	91	2	IPR005481
Domain	CPSase_L_D2	ACACA ACACB	4.85e-04	7	91	2	PF02786
Domain	Biotin_carb_N	ACACA ACACB	4.85e-04	7	91	2	PF00289
Domain	FN3_dom	FNDC1 IGF1R PTPRC USH2A SDK1 SORL1	5.53e-04	209	91	6	IPR003961
Domain	PH_dom-spectrin-type	PSD PSD3	8.27e-04	9	91	2	IPR001605
Domain	Biotin_lipoyl	ACACA ACACB	8.27e-04	9	91	2	PF00364
Domain	BIOTINYL_LIPOYL	ACACA ACACB	1.03e-03	10	91	2	PS50968
Domain	Biotin_lipoyl	ACACA ACACB	1.03e-03	10	91	2	IPR000089
Domain	TRP_channel	TRPV1 TRPV2	1.25e-03	11	91	2	IPR004729
Domain	JAMM/MPN+_dom	PRPF8 COPS5	1.50e-03	12	91	2	IPR000555
Domain	Single_hybrid_motif	ACACA ACACB	1.50e-03	12	91	2	IPR011053
Domain	JAB_MPN	PRPF8 COPS5	1.50e-03	12	91	2	SM00232
Domain	JAB	PRPF8 COPS5	1.50e-03	12	91	2	PF01398
Domain	-	ACACA ACACB	1.77e-03	13	91	2	3.40.50.20
Domain	ATP_GRASP	ACACA ACACB	2.06e-03	14	91	2	PS50975
Domain	-	HEPHL1 F5	2.06e-03	14	91	2	2.60.40.420
Domain	ATP-grasp	ACACA ACACB	2.06e-03	14	91	2	IPR011761
Domain	PreATP-grasp_dom	ACACA ACACB	2.06e-03	14	91	2	IPR016185
Domain	-	PSD PSD3	2.37e-03	15	91	2	1.10.1000.11
Domain	Sec7	PSD PSD3	2.37e-03	15	91	2	PF01369
Domain	Sec7_alpha_orthog	PSD PSD3	2.37e-03	15	91	2	IPR023394
Domain	-	ACACA ACACB	2.37e-03	15	91	2	3.30.1490.20
Domain	GproteinA_insert	GNA14 GNA11	2.70e-03	16	91	2	IPR011025
Domain	TLC	TRAM1L1 TRAM1	2.70e-03	16	91	2	SM00724
Domain	-	GNA14 GNA11	2.70e-03	16	91	2	1.10.400.10
Domain	SEC7	PSD PSD3	2.70e-03	16	91	2	PS50190
Domain	Sec7	PSD PSD3	2.70e-03	16	91	2	SM00222
Domain	G-alpha	GNA14 GNA11	2.70e-03	16	91	2	PF00503
Domain	TLC	TRAM1L1 TRAM1	2.70e-03	16	91	2	PS50922
Domain	Sec7_dom	PSD PSD3	2.70e-03	16	91	2	IPR000904
Domain	TRAM_LAG1_CLN8	TRAM1L1 TRAM1	2.70e-03	16	91	2	PF03798
Domain	PINT	EIF3C EIF3CL	2.70e-03	16	91	2	SM00088
Domain	TLC-dom	TRAM1L1 TRAM1	2.70e-03	16	91	2	IPR006634
Domain	G_alpha	GNA14 GNA11	2.70e-03	16	91	2	SM00275
Domain	PCI_dom	EIF3C EIF3CL	3.04e-03	17	91	2	IPR000717
Domain	Gprotein_alpha_su	GNA14 GNA11	3.04e-03	17	91	2	IPR001019
Domain	PCI	EIF3C EIF3CL	3.04e-03	17	91	2	PF01399
Domain	ATP_grasp_subdomain_1	ACACA ACACB	3.41e-03	18	91	2	IPR013815
Domain	-	ACACA ACACB	3.41e-03	18	91	2	3.30.470.20
Domain	Pkinase_Tyr	BMX IGF1R BRAF PTK2	3.65e-03	129	91	4	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	BMX IGF1R BRAF PTK2	4.64e-03	138	91	4	IPR001245
Domain	-	ACACA ACACB	4.64e-03	21	91	2	3.90.226.10
Domain	ClpP/crotonase-like_dom	ACACA ACACB	4.64e-03	21	91	2	IPR029045
Domain	RNaseH-like_dom	POLE PARN PRPF8	4.65e-03	69	91	3	IPR012337
Pubmed	STAG3, a novel gene encoding a protein involved in meiotic chromosome pairing and location of STAG3-related genes flanking the Williams-Beuren syndrome deletion.	STAG3L1 STAG3L2 STAG3L3	2.03e-07	5	96	3	10698974
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	IGF1R NDC1 REPS1 BRAF MAP1B DPY19L1 KMT2A PARN EIF3C EIF3J COPS5 PTK2 EIF3CL	1.35e-06	910	96	13	36736316
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	REPS1 EIF3C PRPF8 COPS5 GTF3C3 EIF3CL	4.39e-06	153	96	6	26365490
Pubmed	Characterization of eIF3k: a newly discovered subunit of mammalian translation initiation factor elF3.	EIF3C EIF3J EIF3CL	4.40e-06	12	96	3	14519125
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FAP IGF1R NDC1 GALNT3 MAP1B DPY19L1 TRAM1 TMEM245 SUN1 NAGLU RECQL HIF1AN GTF3C3 SORL1	5.44e-06	1201	96	14	35696571
Pubmed	Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3.	EIF3C EIF3J EIF3CL	7.26e-06	14	96	3	18599441
Pubmed	Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation.	TRPV1 TRPV2	7.54e-06	2	96	2	24641282
Pubmed	Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation.	ACACA ACACB	7.54e-06	2	96	2	24944901
Pubmed	Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain.	BMX PTK2	7.54e-06	2	96	2	11331870
Pubmed	Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death.	TRPV1 TRPV2	7.54e-06	2	96	2	19619644
Pubmed	EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.	EIF3C EIF3CL	7.54e-06	2	96	2	36157221
Pubmed	Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.	ACACA ACACB	7.54e-06	2	96	2	20139635
Pubmed	Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.	ACACA ACACB	7.54e-06	2	96	2	28081256
Pubmed	Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.	ACACA ACACB	7.54e-06	2	96	2	26976583
Pubmed	Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3.	GALNT3 BRAF	7.54e-06	2	96	2	29894293
Pubmed	Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex.	TRPV1 TRPV2	7.54e-06	2	96	2	16115206
Pubmed	Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood.	TRPV1 TRPV2	7.54e-06	2	96	2	16777226
Pubmed	FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.	IGF1R PTK2	7.54e-06	2	96	2	18263593
Pubmed	Identification of the MMRN1 binding region within the C2 domain of human factor V.	MMRN1 F5	7.54e-06	2	96	2	15452129
Pubmed	AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation.	ACACA ACACB	7.54e-06	2	96	2	25001074
Pubmed	Distribution of TRPV1 and TRPV2 in the human stellate ganglion and spinal cord.	TRPV1 TRPV2	7.54e-06	2	96	2	25641129
Pubmed	The subcellular localization of acetyl-CoA carboxylase 2.	ACACA ACACB	7.54e-06	2	96	2	10677481
Pubmed	Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.	ACACA ACACB	7.54e-06	2	96	2	24338821
Pubmed	Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells.	BRAF PTK2	7.54e-06	2	96	2	20407018
Pubmed	Human platelets contain forms of factor V in disulfide-linkage with multimerin.	MMRN1 F5	7.54e-06	2	96	2	15583744
Pubmed	De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.	ACACA ACACB	7.54e-06	2	96	2	25282359
Pubmed	Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.	ACACA ACACB	7.54e-06	2	96	2	27693630
Pubmed	Targeting of the protein interaction site between FAK and IGF-1R.	IGF1R PTK2	7.54e-06	2	96	2	19664602
Pubmed	TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception.	TRPV1 TRPV2	7.54e-06	2	96	2	21832173
Pubmed	Effects of PKB/Akt inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue.	ACACA ACACB	7.54e-06	2	96	2	32215608
Pubmed	Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor.	ACACA ACACB	7.54e-06	2	96	2	29772612
Pubmed	Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin.	ACACA ACACB	7.54e-06	2	96	2	29976587
Pubmed	Structure and regulation of acetyl-CoA carboxylase genes of metazoa.	ACACA ACACB	7.54e-06	2	96	2	15749055
Pubmed	ASIC2 Synergizes with TRPV1 in the Mechano-Electrical Transduction of Arterial Baroreceptors.	TRPV1 ASIC2	7.54e-06	2	96	2	34215968
Pubmed	Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.	TRPV1 TRPV2	7.54e-06	2	96	2	24322617
Pubmed	Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.	IGF1R PTK2	7.54e-06	2	96	2	21338601
Pubmed	Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth.	IGF1R PTK2	7.54e-06	2	96	2	22894899
Pubmed	Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits and its role in ribosomal dissociation and anti-association.	EIF3J EIF3CL	7.54e-06	2	96	2	15703437
Pubmed	Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor.	IGF1R PTK2	7.54e-06	2	96	2	19545541
Pubmed	AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis.	ACACA ACACB	7.54e-06	2	96	2	29433631
Pubmed	Nociceptors lacking TRPV1 and TRPV2 have normal heat responses.	TRPV1 TRPV2	7.54e-06	2	96	2	15254097
Pubmed	Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.	IGF1R PTK2	7.54e-06	2	96	2	28757207
Pubmed	Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease.	TRPV1 TRPV2	7.54e-06	2	96	2	23453732
Pubmed	Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.	ACACA ACACB	7.54e-06	2	96	2	36076520
Pubmed	Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via α-actinin and focal adhesion kinase.	IP6K1 PTK2	7.54e-06	2	96	2	28154132
Pubmed	Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.	ACACA ACACB	7.54e-06	2	96	2	28290443
Pubmed	Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.	ACACA ACACB	7.54e-06	2	96	2	30244972
Pubmed	A capsaicin-receptor homologue with a high threshold for noxious heat.	TRPV1 TRPV2	7.54e-06	2	96	2	10201375
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	IGF1R PTPRC ACACA TMEM245 SUN1 NAGLU PRPF8 COPS5 SDHA SORL1	7.79e-06	613	96	10	22268729
Pubmed	Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry.	EIF3C EIF3J EIF3CL	9.05e-06	15	96	3	17322308
Pubmed	AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue.	ACACA ACACB	2.26e-05	3	96	2	34668531
Pubmed	AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation.	ACACA ACACB	2.26e-05	3	96	2	30018077
Pubmed	Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.	IGF1R SDHA	2.26e-05	3	96	2	23109135
Pubmed	Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels.	ACACA ACACB	2.26e-05	3	96	2	19846279
Pubmed	Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.	ACACA ACACB	2.26e-05	3	96	2	18031993
Pubmed	Extent of intrinsic disorder and NMR chemical shift assignments of the distal N-termini from human TRPV1, TRPV2 and TRPV3 ion channels.	TRPV1 TRPV2	2.26e-05	3	96	2	35666427
Pubmed	Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis.	ACACA ACACB	2.26e-05	3	96	2	20457939
Pubmed	Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism.	ACACA ACACB	2.26e-05	3	96	2	36417534
Pubmed	High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms.	GNA14 GNA11	2.26e-05	3	96	2	31189994
Pubmed	A heat-sensitive TRP channel expressed in keratinocytes.	TRPV1 TRPV2	2.26e-05	3	96	2	12016205
Pubmed	Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate.	ACACA ACACB	2.26e-05	3	96	2	18455495
Pubmed	Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells.	TRPV1 TRPV2	2.26e-05	3	96	2	22327830
Pubmed	Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.	MMRN1 F5	2.26e-05	3	96	2	19132231
Pubmed	Citric Acid in Drug Formulations Causes Pain by Potentiating Acid-Sensing Ion Channel 1.	TRPV1 ASIC2	2.26e-05	3	96	2	33888605
Pubmed	Transient receptor potential vanilloid 1, vanilloid 2 and melastatin 8 immunoreactive nerve fibers in human skin from individuals with and without Norrbottnian congenital insensitivity to pain.	TRPV1 TRPV2	2.26e-05	3	96	2	19482060
Pubmed	Thermosensitive transient receptor potential channels in human corneal epithelial cells.	TRPV1 TRPV2	2.26e-05	3	96	2	21506114
Pubmed	Next-generation sequencing to solve complex inherited retinal dystrophy: A case series of multiple genes contributing to disease in extended families.	PRPF8 USH2A	2.26e-05	3	96	2	28761320
Pubmed	Analysis of TRPV channel activation by stimulation of FCεRI and MRGPR receptors in mouse peritoneal mast cells.	TRPV1 TRPV2	2.26e-05	3	96	2	28158279
Pubmed	Expression and distribution of three transient receptor potential vanilloid(TRPV) channel proteins in human odontoblast-like cells.	TRPV1 TRPV2	2.26e-05	3	96	2	28905239
Pubmed	Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.	ACACA ACACB	2.26e-05	3	96	2	28877461
Pubmed	Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis.	BRAF PTK2	2.26e-05	3	96	2	30531837
Pubmed	Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.	ACACA ACACB	2.26e-05	3	96	2	17521700
Pubmed	TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells.	IGF1R PTK2	2.26e-05	3	96	2	19020730
Pubmed	Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.	ACACA ACACB	2.26e-05	3	96	2	31990961
Pubmed	Up-regulation of transient receptor potential vanilloid (TRPV) and down-regulation of brain-derived neurotrophic factor (BDNF) expression in patients with functional dyspepsia (FD).	TRPV1 TRPV2	2.26e-05	3	96	2	28782273
Pubmed	The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.	ACACA ACACB	2.26e-05	3	96	2	27381369
Pubmed	Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.	ACACA ACACB	2.26e-05	3	96	2	17210641
Pubmed	Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.	KCTD20 PTK2	2.26e-05	3	96	2	28398603
Pubmed	Expression of transient receptor potential vanilloid (TRPV) 1, 2, 3, and 4 in mouse inner ear.	TRPV1 TRPV2	2.26e-05	3	96	2	18607942
Pubmed	Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.	ACACA ACACB	2.26e-05	3	96	2	28768177
Pubmed	CIF-1, a shared subunit of the COP9/signalosome and eukaryotic initiation factor 3 complexes, regulates MEL-26 levels in the Caenorhabditis elegans embryo.	EIF3C EIF3J COPS5	2.61e-05	21	96	3	17403899
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	BMX IGF1R ACACA BRAF MAP1B PI4KA PSD3 KMT2A BOD1L1 INPP5F EIF3J	2.61e-05	861	96	11	36931259
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	MAP1B MYO1E PI4KA KCTD20 BOD1L1 INPP5F GTF3C3	2.69e-05	313	96	7	38270169
Pubmed	Genomic variants in an inbred mouse model predict mania-like behaviors.	FNDC1 TRPV1 POLR3C	3.47e-05	23	96	3	29768498
Pubmed	Global landscape of HIV-human protein complexes.	DPY19L1 POLE SUN1 RECQL EIF3C EIF3J COPS5 SDHA	4.04e-05	457	96	8	22190034
Pubmed	Promiscuous coupling of receptors to Gq class alpha subunits and effector proteins in pancreatic and submandibular gland cells.	GNA14 GNA11	4.51e-05	4	96	2	9765251
Pubmed	Expression Profiles of ASIC1/2 and TRPV1/4 in Common Skin Tumors.	TRPV1 ASIC2	4.51e-05	4	96	2	34199609
Pubmed	Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.	PTPRC B2M	4.51e-05	4	96	2	24639353
Pubmed	Quantitative Real-Time PCR detection of TRPV1-4 gene expression in human leukocytes from healthy and hyposensitive subjects.	TRPV1 TRPV2	4.51e-05	4	96	2	18983665
Pubmed	Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.	ACACA ACACB	4.51e-05	4	96	2	24185692
Pubmed	Expression of transient receptor potential vanilloid (TRPV) families 1, 2, 3 and 4 in the mouse olfactory epithelium.	TRPV1 TRPV2	4.51e-05	4	96	2	19839244
Pubmed	Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2.	IGF1R PTK2	4.51e-05	4	96	2	35154476
Pubmed	Hypothalamic Rax+ tanycytes contribute to tissue repair and tumorigenesis upon oncogene activation in mice.	IGF1R BRAF	4.51e-05	4	96	2	33863883
Pubmed	Crystal structure of Spot 14, a modulator of fatty acid synthesis.	ACACA ACACB	4.51e-05	4	96	2	20952656
Pubmed	Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways.	BMX PTK2	4.51e-05	4	96	2	18292575
Pubmed	Nicotinic acid is a common regulator of heat-sensing TRPV1-4 ion channels.	TRPV1 TRPV2	4.51e-05	4	96	2	25752528
Pubmed	Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability.	ACACA ACACB	4.51e-05	4	96	2	38447582
Pubmed	Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.	IGF1R PTK2	4.51e-05	4	96	2	25391374
Pubmed	SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.	BRAF GNA11	4.51e-05	4	96	2	29059311
Pubmed	Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies.	EIF3C EIF3CL	4.51e-05	4	96	2	10504338
GeneFamily	Fibronectin type III domain containing	FNDC1 IGF1R PTPRC USH2A SDK1 SORL1	2.15e-05	160	64	6	555
GeneFamily	TLC domain containing	TRAM1L1 TRAM1	5.45e-04	10	64	2	1374
GeneFamily	Eukaryotic translation initiation factor 3	EIF3C EIF3J	9.38e-04	13	64	2	1121
Coexpression	ONKEN_UVEAL_MELANOMA_UP	PTPRC ACACB SACS TRAM1 B2M ABHD3 TRPV2 RECQL COPS5 PTK2 SDHA SORL1 POLR3C	6.19e-06	790	96	13	M12490
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MS4A18 POLE HEPHL1 USH2A F5 PKHD1L1	1.41e-06	162	96	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX PTPRC ACACB CCNB3 TMEM245 PLCG2	1.86e-06	170	96	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	MMRN1 BMX GNA14 CHST15 B2M PKHD1L1	3.76e-06	192	96	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	MMRN1 SHROOM4 BMX GNA14 B2M PKHD1L1	3.88e-06	193	96	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	MYO1E SUN1 PLCG2 INPP5F PTK2 PARP15	3.88e-06	193	96	6	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	MMRN1 SHROOM4 BMX GNA14 B2M PKHD1L1	3.88e-06	193	96	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	MMRN1 SHROOM4 BMX GNA14 B2M PKHD1L1	3.99e-06	194	96	6	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	MMRN1 SHROOM4 PSD RCBTB2 PLCG2	1.51e-05	144	96	5	6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	TRAM1L1 ACACA JMJD7 DPY19L1 GTF3C3	1.57e-05	145	96	5	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MS4A18 RBM44 POLE HEPHL1 USH2A	1.57e-05	145	96	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	TRAM1L1 ACACA JMJD7 DPY19L1 GTF3C3	1.57e-05	145	96	5	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRC EFCAB6 B2M RASGEF1C EPGN	1.73e-05	148	96	5	7cb4865a1e9522e24f9c14799568b67172bd99dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CHST15 B2M TLR8 SORL1	3.46e-05	171	96	5	ef9397cec7f5c217d34583f26270af7ed7fbcebf
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SACS BOD1L1 PLCG2 PTK2 PARP15	3.76e-05	174	96	5	ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BMX TRANK1 NDC1 KCNV2 RASGEF1C	3.86e-05	175	96	5	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MMRN1 CLCA1 NSG1 DNAH6 PKHD1L1	3.97e-05	176	96	5	460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MMRN1 BMX MAP1B KIF18B PKHD1L1	4.65e-05	182	96	5	f703963b5d1e8c1f95d78807521048553b0792d8
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MMRN1 BMX MAP1B KIF18B PKHD1L1	4.65e-05	182	96	5	ebd177ad5eac51bf2db0657596618bdf1e5d46e1
ToppCell	severe-Myeloid-Neutrophils_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PTPRC CHST15 B2M BOD1L1 SORL1	4.77e-05	183	96	5	60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMRN1 NDC1 CLCA1 DNAH6 PKHD1L1	4.77e-05	183	96	5	919c9861073d12fd12aecd7469b1478b13838c43
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 EFCAB6 USH2A PKHD1L1 SDK1	4.90e-05	184	96	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 EFCAB6 USH2A PKHD1L1 SDK1	4.90e-05	184	96	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 EFCAB6 USH2A PKHD1L1 SDK1	4.90e-05	184	96	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	MMRN1 SHROOM4 BMX B2M PKHD1L1	5.29e-05	187	96	5	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MMRN1 SHROOM4 GNA14 PKHD1L1 PTK2	5.29e-05	187	96	5	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.29e-05	187	96	5	65d406122dffe18279f14a1ed35ba091730b97be
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.29e-05	187	96	5	4c15c0ed41a55271fc793cb76fee97fa64190369
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.29e-05	187	96	5	5274f2b302bbf7fed30c480af4f35058d2cf61e0
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.43e-05	188	96	5	26915db8863f4115b46a81982e187322e21600fd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.43e-05	188	96	5	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.43e-05	188	96	5	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MMRN1 BMX GNA14 F5 PKHD1L1	5.56e-05	189	96	5	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	MMRN1 SHROOM4 BMX GNA14 PKHD1L1	5.56e-05	189	96	5	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	MYO1E PLCG2 INPP5F PTK2 PARP15	5.56e-05	189	96	5	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.70e-05	190	96	5	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.70e-05	190	96	5	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 BMX MAP1B CHST15 PKHD1L1	5.70e-05	190	96	5	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	control-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	IGF1R TRANK1 B2M BOD1L1 SORL1	5.85e-05	191	96	5	db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCell	cellseq-Endothelial-Endothelial_Lymphatic-LEC-LEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MMRN1 BMX MAP1B CHST15 PKHD1L1	6.45e-05	195	96	5	8321531bb976e5005973b82f32177be88113abb3
ToppCell	cellseq-Endothelial-Endothelial_Lymphatic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MMRN1 BMX MAP1B CHST15 PKHD1L1	6.45e-05	195	96	5	d8f01746c8f92532bd1a5c1b0bbb86208d64c3cd
ToppCell	cellseq-Endothelial-Endothelial_Lymphatic-LEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MMRN1 BMX MAP1B CHST15 PKHD1L1	6.45e-05	195	96	5	918b68a271a81202778714e10b09c5c724575b73
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TRANK1 PTPRC B2M KMT2A PARP15	6.77e-05	197	96	5	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC TRAM1L1 B2M PLCG2 PARP15	6.93e-05	198	96	5	4aa4ae2571effcfb6eb6923f7173cd3e7e4af9ef
ToppCell	COVID-19_Severe-Neu_1\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	PTPRC B2M F5 TLR8 SORL1	6.93e-05	198	96	5	bbe639ea5a636c985e509fb0a133ae3b60afac5a
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	IGF1R ACACA BRAF SDK1 PTK2	6.93e-05	198	96	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC B2M CCR4 F5 SORL1	6.93e-05	198	96	5	7608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCell	COVID-19_Severe-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	PTPRC B2M F5 TLR8 SORL1	7.10e-05	199	96	5	e4d8bf016fd95a440e30014a75587e097e90cfad
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MMRN1 BMX MAP1B CHST15 PKHD1L1	7.27e-05	200	96	5	76e90231aa94afc12e618da8ae314c51644acab4
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MMRN1 SHROOM4 BMX SSTR1 PKHD1L1	7.27e-05	200	96	5	98f6a86fbbe5305c71dae91e7278de9813827935
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MMRN1 BMX MAP1B CHST15 PKHD1L1	7.27e-05	200	96	5	e3e80cb16e0d2e24efc16b62316a6da91bf81ea5
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Macrophages\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MMRN1 SHROOM4 BMX SSTR1 PKHD1L1	7.27e-05	200	96	5	d7b89a721988660d8010c804916f5d0ef2520ee2
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MMRN1 SHROOM4 BMX SSTR1 PKHD1L1	7.27e-05	200	96	5	1ed1c673184f0c6aae04f90edbb1383b1c1f64d9
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MMRN1 SHROOM4 BMX SSTR1 PKHD1L1	7.27e-05	200	96	5	2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MMRN1 SHROOM4 BMX SSTR1 PKHD1L1	7.27e-05	200	96	5	9e5627e11288713aa9b622aae40e849dd6eacd29
ToppCell	(11)_Activated_CD4_T\|World / shred on Cell_type and subtype	PTPRC B2M CCR4 EPGN SORL1	7.98e-05	204	96	5	5c085c5335bf69c18fa298efa137e9bf529eefc6
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-11\|TCGA-Brain / Sample_Type by Project: Shred V9	BMX IGHV3-21 GNA14 SDK1	1.65e-04	127	96	4	7c3f8c791567fff5d2f42c2c7d09c78ec6ca3afe
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5\|TCGA-Brain / Sample_Type by Project: Shred V9	RNF103 MEIKIN LCAT F5	2.20e-04	137	96	4	a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Npnt_(Layer_5a)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CIDEC USH2A DNAH6	2.40e-04	56	96	3	112a412816287423089c0333a42432a6ab4500dc
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_2\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	PTPRC CCNB3 NSG1 EIF3CL	2.52e-04	142	96	4	435f39976841438690fcbf85bfa8e7f5b9e43916
ToppCell	ASK440-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	MMRN1 PTPRC B2M TLR8	2.52e-04	142	96	4	ea694a907eaa46c55665692cb830870281700e40
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GNA14 GALNT3 TRPV2 F5	2.66e-04	144	96	4	013223bb2f31eb5bebdbd0908b797d28b96c6f7b
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MMRN1 EPGN PKHD1L1	2.81e-04	59	96	3	ebc80c32b56e97c3ab3ac5ae00f06f7f2bcc3d39
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MMRN1 EPGN PKHD1L1	2.81e-04	59	96	3	719728ed089762ae79cbfbe56c4171d70361a772
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MMRN1 EPGN PKHD1L1	2.81e-04	59	96	3	55954d610f5a813ef15ab5e898c5ad309fc9e319
ToppCell	COVID-19-kidney-Lymphatic_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MMRN1 BMX CHST15 PKHD1L1	2.95e-04	148	96	4	f777aa1674e898e2594b2b7c029d3d05dda04df9
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRANK1 PTPRC B2M SORL1	3.19e-04	151	96	4	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	Control-Myeloid-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMX PTPRC PLCG2 SORL1	3.35e-04	153	96	4	c33d63b2d1a220bc428e776b157b23faa43ea8ca
ToppCell	Control-Myeloid-Neutrophils-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMX PTPRC PLCG2 SORL1	3.35e-04	153	96	4	e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRC B2M RASGEF1C EPGN	3.35e-04	153	96	4	e25ddf75d78edfac962c8ec503c9f70f0f7f25bc
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGHV3-21 JMJD7 NAGLU PKHD1L1	3.52e-04	155	96	4	881422c57d230c0e2e5f9098ab888caa94ca61aa
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRC EFCAB6 B2M TRPV2	3.52e-04	155	96	4	4ae91bc7dbb9f713a1f110c17834b1d89f1b28db
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRC EFCAB6 B2M TRPV2	3.52e-04	155	96	4	fdcc8a475156329b3594d5ed22ba03538305327c
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRC EFCAB6 B2M TRPV2	3.52e-04	155	96	4	1fb49b48e34e740118908951e079ea2a9994ae4f
ToppCell	Control-Epithelial-Ionocyte\|Epithelial / Disease state, Lineage and Cell class	CCNB3 TRPV2 PLCG2 SORL1	3.52e-04	155	96	4	4b9369b203a4d7071c56d3d8e6b450e9a0121c41
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRC POLE B2M EIF3J	3.61e-04	156	96	4	33deda19f06172079ef1dd49fd54d66da1e7fb14
ToppCell	metastatic_Brain-T/NK_cells-Naive_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	PTPRC B2M NSG1 PLCG2	3.61e-04	156	96	4	1dcb0b2d1c4b524e692d40e8403dbf7140af19b4
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPRC B2M SORL1 PARP15	3.69e-04	157	96	4	170197b76620df31495f1247f365da382b2d8045
ToppCell	facs-Lung-Endomucin_-18m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX PTPRC F5 SORL1	3.69e-04	157	96	4	2b60de520edf167f5ca790b478557a778435b3d9
ToppCell	PND07-28-samps\|World / Age Group, Lineage, Cell class and subclass	PTPRC CIDEC B2M PLCG2	3.69e-04	157	96	4	a2005768a6d268879e3fd6dbd8cf674dc98be587
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPRC B2M SORL1 PARP15	3.69e-04	157	96	4	c21520301cc0d5d4b1cc4b8ec735f9adb698e768
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMRN1 BRAF INPP5F F5	3.69e-04	157	96	4	a426c54fd1545093d41426e9620862f71bd06f6b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPRC B2M SORL1 PARP15	3.78e-04	158	96	4	7274f020c0ecf216da4b6689c62bc5f49c29b6f3
ToppCell	facs-Liver\|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGN PTPRC B2M LCAT	3.78e-04	158	96	4	ea7db6bd9742153ceb6e444892a6d1df9c7fcc96
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNV2 HEPHL1 USH2A PKHD1L1	3.97e-04	160	96	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNV2 HEPHL1 USH2A PKHD1L1	3.97e-04	160	96	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAP FNDC1 SACS KIF18B	4.06e-04	161	96	4	a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAP FNDC1 SACS KIF18B	4.06e-04	161	96	4	08920a716f6ec62538e361211455a30ad726d7be
ToppCell	E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated\|E18.5-samps / Age Group, Lineage, Cell class and subclass	BMX PTPRC PLCG2 TLR8	4.16e-04	162	96	4	60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed
ToppCell	E18.5-samps-Myeloid\|E18.5-samps / Age Group, Lineage, Cell class and subclass	BMX PTPRC PLCG2 TLR8	4.16e-04	162	96	4	18e4a807e25f754a69e9eaaddfde40f8de9b8512
ToppCell	droplet-Marrow-BM-30m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD LCAT TLR8 POLR3C	4.16e-04	162	96	4	75df7ff779a3b9159ba97d852da1f8df650b9ce5
ToppCell	E18.5-samps-Myeloid-Macrophage\|E18.5-samps / Age Group, Lineage, Cell class and subclass	BMX PTPRC PLCG2 TLR8	4.16e-04	162	96	4	0970e4eda60e3f015335e2726e6d565fb2f43372
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGN BMX PTPRC DNAH6	4.26e-04	163	96	4	57f02f2b9ce940a2962bb57cd8d02eb67b6f44a3
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGN BMX PTPRC DNAH6	4.26e-04	163	96	4	155ac52a34e0d55545aab8a3e4162fc4c387e697
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGN BMX PTPRC DNAH6	4.26e-04	163	96	4	c132fb5b56186a10d33ae5ce17b2a7e670d52f79
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC CIDEC PLCG2 EPGN	4.36e-04	164	96	4	15d52666e5150e7c34b1f641a937fb2d5e8aaf8a
ToppCell	facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC CIDEC PLCG2 EPGN	4.36e-04	164	96	4	d622f0d8d8bad48dfdf160ec63c545df192637a9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 MAP1B CHST15 PKHD1L1	4.36e-04	164	96	4	a784f47f67a5eda84d58ad7d9400e3978edbb487
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 MAP1B CHST15 PKHD1L1	4.36e-04	164	96	4	1a1795969673232191425dde84ab24ee6a98143f
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMRN1 CLCA1 NSG1 PKHD1L1	4.36e-04	164	96	4	4cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MMRN1 MAP1B CHST15 PKHD1L1	4.36e-04	164	96	4	8f074940afdbda88a4b697a7ddc687e09a4b818b
Disease	quality of life during menstruation measurement	ASIC2 TMEM245	1.02e-04	5	95	2	EFO_0009366
Disease	muscular disease (implicated_via_orthology)	ACACA ACACB	1.02e-04	5	95	2	DOID:0080000 (implicated_via_orthology)
Disease	Liver carcinoma	IGF1R ACACA BRAF KMT2A LCAT KIF18B COPS5 PTK2	2.36e-04	507	95	8	C2239176
Disease	high grade glioma (implicated_via_orthology)	IGF1R BRAF POLE	3.89e-04	44	95	3	DOID:3070 (implicated_via_orthology)
Disease	Neuroendocrine Tumors	BRAF SSTR1	5.54e-04	11	95	2	C0206754
Disease	coronary artery calcification	RBM44 CLCA1 MYO1E NSG1 PSD3 EPGN DNAH6	6.39e-04	450	95	7	EFO_0004723
Disease	endometrial carcinoma (is_implicated_in)	BRAF POLE	6.63e-04	12	95	2	DOID:2871 (is_implicated_in)
Disease	familial hyperlipidemia (implicated_via_orthology)	RGN LCAT	6.63e-04	12	95	2	DOID:1168 (implicated_via_orthology)
Disease	interleukin 12 measurement	SACS KCNV2 PSD3	6.74e-04	53	95	3	EFO_0004753
Disease	left ventricular diastolic function measurement	IGF1R MYO1E PTK2	7.12e-04	54	95	3	EFO_0008204
Disease	Chronic Lymphocytic Leukemia	IGHV3-21 BRAF PLCG2	7.51e-04	55	95	3	C0023434
Disease	opioid dependence	RBM44 MAP1B CHST15 RASGEF1C PLCG2	1.03e-03	237	95	5	EFO_0005611
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	KCNV2 F5	1.20e-03	16	95	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	IGF1R ACACA ACACB	1.22e-03	65	95	3	DOID:0080208 (biomarker_via_orthology)
Disease	stem Cell Factor measurement	PLCG2 LCAT F5	1.33e-03	67	95	3	EFO_0008291
Disease	Parkinson's disease (is_marker_for)	IGF1R B2M SDHA	1.33e-03	67	95	3	DOID:14330 (is_marker_for)
Disease	Benign neoplasm of stomach	BRAF POLE	1.35e-03	17	95	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	BRAF POLE	1.35e-03	17	95	2	C0496905
Disease	Carcinoma in situ of stomach	BRAF POLE	1.35e-03	17	95	2	C0154060
Disease	Malignant Glioma	BRAF PSD3 CCR4	1.51e-03	70	95	3	C0555198
Disease	mixed gliomas	BRAF PSD3 CCR4	1.51e-03	70	95	3	C0259783
Disease	Adrenocortical carcinoma	IGF1R BRAF	1.52e-03	18	95	2	C0206686
Disease	Paroxysmal atrial fibrillation	IGF1R SUN1 PTK2 SORL1	1.65e-03	156	95	4	C0235480
Disease	familial atrial fibrillation	IGF1R SUN1 PTK2 SORL1	1.65e-03	156	95	4	C3468561
Disease	Persistent atrial fibrillation	IGF1R SUN1 PTK2 SORL1	1.65e-03	156	95	4	C2585653
Disease	Atrial Fibrillation	IGF1R SUN1 PTK2 SORL1	1.81e-03	160	95	4	C0004238
Disease	prostate adenocarcinoma (is_implicated_in)	IGF1R BRAF	1.88e-03	20	95	2	DOID:2526 (is_implicated_in)
Disease	Colorectal Carcinoma	ACACA BRAF MAP1B SACS CCNB3 POLE F5 SORL1	1.95e-03	702	95	8	C0009402
Disease	Stomach Carcinoma	BRAF POLE	2.07e-03	21	95	2	C0699791
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	PLCG2 F5	2.07e-03	21	95	2	EFO_0004286, EFO_0004792
Disease	venous thromboembolism, tissue plasminogen activator measurement	PLCG2 F5	2.48e-03	23	95	2	EFO_0004286, EFO_0004791
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ACACB PSD3 EIF3J	2.73e-03	86	95	3	EFO_0008595, EFO_0020945
Disease	Glioma	BRAF PSD3 CCR4	2.82e-03	87	95	3	C0017638
Disease	fatty acid measurement	ACACB ABHD3 PSD3 KMT2A EIF3J HIF1AN	2.89e-03	436	95	6	EFO_0005110
Disease	inflammatory biomarker measurement	KCNV2 F5	3.17e-03	26	95	2	EFO_0004872

Protein segments in the cluster

Peptide	Gene	Start	Entry
SFYLLYYTEFTPTEK	B2M	81	P61769
YYALEVSYFKSSLDR	COPS5	221	Q92905
TSYAVDSYEKYIAIG	EPGN	101	Q6UW88
SIYLEAYEEYTSKLD	BRAF	76	P15056
FVLTKTNLSYYEYDK	BMX	31	P51813
SVAYAFYYLSSIAKK	ABHD3	41	Q8WU67
SGYYLDISLYKEVTD	ACACA	1536	Q13085
IADTTLDESIYSNYY	CCR4	6	P51679
YYTIQDEAYDTTDSL	FLG	236	P20930
LTFSSYDSLKAVYYK	CCNB3	1346	Q8WWL7
LVSLYYEEARSAYLS	NAGLU	571	P54802
LLVESSERVSYYFSY	ASIC2	56	Q16515
YRAFLEYLYTDSISL	RCBTB2	441	O95199
YDSTNYRYASLAFTK	RBM44	861	Q6ZP01
LCTFKYDYTDSKYIT	PARN	71	O95453
YDYTDSKYITKSFNF	PARN	76	O95453
GYYLDISLYKEVTDS	ACACB	1656	O00763
YFAVDASYSAKDTYS	PARP15	591	Q460N3
TYSYETSDLCYTAEK	MAP1B	2056	P46821
SVYSASTHKFLYYDE	HIF1AN	91	Q9NWT6
KITQYEKSLYYASFL	EIF3J	166	O75822
EEYSQILYSSKLYRF	KCTD20	281	Q7Z5Y7
YDLKYSYFQLLDSLT	JMJD7	296	P0C870
YLGVYVFKYTIESFS	MMRN1	1141	Q13201
TSKEVYFYTGSYIRL	GABRQ	241	Q9UN88
DYRDLISFTVYYKEA	IGF1R	516	P08069
LYYSYFKTIVEAPSF	DPY19L1	66	Q2PZI1
SADLYYTSFSDPLYL	PI4KA	361	P42356
SSLLSYSVTDSYAEY	MEIKIN	126	A0A087WXM9
YSVTDSYAEYKSFEE	MEIKIN	131	A0A087WXM9
YYAEQDSSAREKFYT	NSG1	131	P42857
ATYSVSDAVATYYLY	POLE	456	Q07864
TSAYFESLVELVSYY	PLCG2	706	P16885
EISYSLYYSSQEIDK	PCDHB15	276	Q9Y5E8
SSSSSYIYYADSVKG	IGHV3-21	71	A0A0B4J1V1
YIYYADSVKGRFTIS	IGHV3-21	76	A0A0B4J1V1
SSLTYEDTYNTLKYA	KIF18B	331	Q86Y91
ELLSSEENYYSTSYS	ARHGAP12	316	Q8IWW6
LYSKYYSDSDDELTV	BOD1L1	476	Q8NFC6
ESLRTYLFTYSSVYD	EIF3C	786	Q99613
EESLRTYLFTYSSVY	EIF3CL	786	B5ME19
SSIEYDTYNLKVVSY	DNAH6	211	Q9C0G6
TLEEDYKYSESGIYF	DNAH6	3776	Q9C0G6
YSEIEEFYQKLSSRY	HS1BP3	71	Q53T59
YYDKTLSSKISYNDF	EFCAB6	1481	Q5THR3
LFSISKEYFEYIGSY	GALNT3	366	Q14435
YKIYLSDNLKDTFYS	FNDC1	1806	Q4ZHG4
YQLSDSAKYYLTDVD	GNA11	151	P29992
AAYEKFFSSYLVTLT	GRTP1	26	Q5TC63
DLSLYYVTTYSKAVS	MS4A18	241	Q3C1V0
YYSTVNFVKDTYSGL	HEPHL1	886	Q6MZM0
ASYRFYSSSLLVIYD	IP6K1	326	Q92551
LSTSDEDDLYYYNFT	KMT2A	2671	Q03164
TTYSLVATFSKHFYY	GPR63	331	Q9BZJ6
YSVEYLDSSKLAGYL	LCAT	131	P04180
FYEYSLKLLRYSNTT	RNF103	386	O00237
DDSELTTYSSEYKYI	SDK1	141	Q7Z5N4
MDSESFYYSLTYDLT	INPP5F	171	Q9Y2H2
YSEYKIVSSLDLYKF	SACS	4231	Q9NZJ4
EYQLSDSAKYYLTDI	GNA14	146	O95837
LSFYSEDAVYYAFKI	TAS2R39	101	P59534
LYEDKGLSRFTTYEY	USH2A	2886	O75445
VDYYATALKSRAYSV	SSTR1	351	P30872
KSSDVYVSYDYGKSF	SORL1	131	Q92673
LSDAEQKYYSDLFSY	REPS1	6	Q96D71
KEAYLEFEKSRYSTY	PSD	941	A5PKW4
YDTSYFVEYFALDLL	SDHA	211	P31040
KSCYTTEFYVAYSSN	F5	1986	P12259
YAYQLSTALAYLESK	PTK2	526	Q05397
FSDYYSKLKAYEYTT	KCNV2	496	Q8TDN2
TSYSAYYNISVAKAE	SHROOM4	1271	Q9ULL8
DHKIFYYIDSLSYSV	RGN	161	Q15493
YSTSFLTDSYLKYIG	STAG3L1	36	P0CL83
ELLVDSSLEYYSFYD	GTF3C3	646	Q9Y5Q9
VKATFYDTYSLSYDL	CIDEC	161	Q96AQ7
ERLYSDYLYFASSNK	CHST15	396	Q7LFX5
ATKDDGVYSRYFTTY	CLCA1	651	A8K7I4
KEDYSFTAYATISYL	RECQL	556	P46063
YVSSDDIKETGYTYI	PRPF8	2091	Q6P2Q9
VFSYDAISYYKIFSD	FAP	356	Q12884
YTASFSDYAKYYALV	FAP	451	Q12884
AYYLSFLIATSSYFM	TAS2R7	246	Q9NYW3
SQTFYDAYISYDTKD	TLR8	876	Q9NR97
SLYYYGVKDLATVFF	TRAM1L1	71	Q8N609
YIYTTKTLYSDTGEL	POLR3C	91	Q9BUI4
SLKELVNASYTDSYY	TRPV1	186	Q8NER1
SLDYLTSLFYYIPKS	SLC26A11	391	Q86WA9
YYPEKAYIFTFLLSS	RASGEF1C	56	Q8N431
EYLSKTSKYLTDSEY	TRPV2	96	Q9Y5S1
YSTSFLTDSYLKYIG	STAG3L2	36	P0CL84
YTSTFYGFKEEDYVI	PKHD1L1	2911	Q86WI1
LFYLLSSSDEYYKPV	TMEM245	666	Q9H330
ATESVSLYYYGIKDL	TRAM1	66	Q15629
SLYYYGIKDLATVFF	TRAM1	71	Q15629
YSTSFLTDSYLKYIG	STAG3L3	36	P0CL85
YTYALSSSYSSDALD	SUN1	21	O94901
YSASQFYLEAAAKYL	TRANK1	1861	O15050
SKFDLRIYVYVTSYD	TTLL4	761	Q14679
VKDLQYSTDYTFKAY	PTPRC	541	P08575
NTSLYYSAESLETLY	PSD3	451	Q9NYI0
YYLSLSGSYKVDDID	MYO1E	236	Q12965
SFSDLYSSYVIFYFL	NDC1	61	Q9BTX1